Here, the authors describe biallelic loss-of-function variants in human SHARPIN in individuals with autoinflammation and immunodeficiency, termed sharpenia. They also successfully treat one of these individuals with TNF inhibitors.
- Hirotsugu Oda
- Kalpana Manthiram
- Daniel L. Kastner